Cholangite sclérosante primitive (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "Cholangite sclérosante primitive" in French language version.

refsWebsite

Global rank French rank

7sciencedirect.com

149^th place

80^th place

222^nd place

129^th place

234^th place

147^th place

2,769^th place

931^st place

2,393^rd place

506^th place

9,820^th place

6,032^nd place

2,374^th place

298^th place

lww.com

journals.lww.com

(en) Boonstra K, van Erpecum KJ, van Nieuwkerk KM et al. « Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease » Inflamm Bowel Dis, 2012;18:2270-2276

nature.com

(en) Melum E, Franke A, Schramm C et al. « Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci » Nat Genet, 2011;43:17-19
(en) van Hoogstraten HJ, Vleggaar FP, Boland GJ et al. « Budesonide or prednisone in combination with ursodeoxycholic acid in primary sclerosing cholangitis: a randomized double-blind pilot study » Am J Gastroenterol, 2000;95:2015-2022
(en) Eaton JE, Silveira MG, Pardi DS et al. « High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis » Am J Gastroenterol, 2011;106:1638-1645

nejm.org

(en) Lindor KD, Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group, « Ursodiol for primary sclerosing cholangitis » N Engl J Med, 1997;336:691-695

rsna.org

pubs.rsna.org

(en) Dave M, Elmunzer BJ, Dwamena BA, Higgins PD, « Primary sclerosing cholangitis: meta-analysis of diagnostic performance of MR cholangiopancreatography » Radiology, 2010;256:387-396

sciencedirect.com

(en) Folseraas T, Melum E, Rausch P et al. « Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci » J Hepatol, 2012;57:366-375
(en) Soetikno RM, Lin OS, Heidenreich PA, Young HS, Blackstone MO, « Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis » Gastrointest Endosc, 2002;56:48-54
(en) Claessen MM, Vleggaar FP, Tytgat KM, Siersema PD, van Buuren HR, « High lifetime risk of cancer in primary sclerosing cholangitis » J Hepatol, 2009;50:158-164
(en) Sinakos E, Saenger AK, Keach J, Kim WR, Lindor KD, « Many patients with primary sclerosing cholangitis and increased serum levels of carbohydrate antigen 19-9 do not have cholangiocarcinoma » Clin Gastroenterol Hepatol, 2011;9:434-439
(en) European Association for the Study of the Liver, « EASL Clinical Practice Guidelines: management of cholestatic liver diseases » J Hepatol, 2009;51:237-267
(en) Olsson R, Boberg KM, de Muckadell OS et al. « High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled study » Gastroenterology, 2005;129:1464-1472
(en) Stiehl A, Rudolph G, Kloters-Plachky P, Sauer P, Walker S, « Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment » J Hepatol, 2002;36:151-156

thelancet.com

(en) Hirschfield GM, Karlsen TH, Lindor KD, Adams DH, « Primary sclerosing cholangitis » Lancet, 2013;382:1587-1599

wiley.com

onlinelibrary.wiley.com

(en) Molodecky NA, Kareemi H, Parab R et al. « Incidence of primary sclerosing cholangitis: a systematic review and meta-analysis » Hepatology, 2011;53:1590-1599
(en) Janse M, Lamberts LE, Franke L et al. « Three ulcerative colitis susceptibility loci are associated with primary sclerosing cholangitis and indicate a role for IL2, REL, and CARD9 » Hepatology, 2011;53:1977-1985
(en) Ellinghaus D, Folseraas T, Holm K et al. « Genome-wide association analysis in sclerosing cholangitis and ulcerative colitis identifies risk loci at GPR35 and TCF4 » Hepatology, 2012;10.1002/hep.25977
(en) Chapman R, Fevery J, Kalloo A et al. « Diagnosis and management of primary sclerosing cholangitis » Hepatology, 2010;51:660-678
(en) Lindor KD, Kowdley KV, Luketic VA, et al. « High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis » Hepatology, 2009;50:808-814
(en) Farkkila M, Karvonen AL, Nurmi H et al. « Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis: a randomized placebo-controlled trial » Hepatology, 2004;40:1379-1386

www3.interscience.wiley.com

(en) LaRusso NF, Shneider BL, Black D, Gores GJ, James SP, Doo E et al. « Primary sclerosing cholangitis: summary of a workshop » Hepatology, 2006;44:746-64